Actively Recruiting
High Flow Nasal Cannulae vs Venturi Mask in Respiratory Failure Due to Pneumonia
Led by Papa Giovanni XXIII Hospital · Updated on 2024-03-07
150
Participants Needed
1
Research Sites
160 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The primary objective of this study is to compare the efficacy of treatment with HFNC (group A) compared to administration of oxygen therapy by Venturi mask (group B, standard therapy) in terms of reaching of endotracheal intubation criteria during acute respiratory failure due to severe pneumonia. Inclusion Criteria: Respiratory rate (RR) at rest ≥20 bpm or presence of respiratory distress (severe dyspnoea at rest or use of accessory respiratory muscles or abdominal paradox); PaO2 / FiO2 ≤250 during oxygenation with Venturi Oxygenation mask at FiO2 = 50% administered for at least 60 minutes; Diagnosis of pneumonia as the sole cause of acute respiratory failure. Randomization: 150 consecutive patients will be randomized either to High Flow Nasal Cannula Oxygenation (75 patients, HFNCO with flow ≥ 60 L/min and FiO2 to maintain SpO2 ≥ ) or Venturi Mask Oxygenation (control, 75 patients). Patients from both groups will be treated with antibiotic therapy according to the IDSA/ATS 2007 guidelines for community-acquired pneumonia and the IDSA/ATS 2016 guidelines for hospital-acquired pneumonia. Intubation Criteria: MAJOR CRITERIA: Cardiac or respiratory arrest Breathing pauses with loss of consciousness Severe hemodynamic instability Need for sedation MINOR CRITERIA (maintained for ≥1h): Reduction ≥30% of the value of the PaO2/FiO 2 compared to baseline Increased 20% if PaCO2 PaCO2 previous ≥40mmHg Worsening alertness as increased by one degree on the Kelly scale Persistence or onset of respiratory distress Vital parameters, Kelly scale and arterial blood gas analysis (BGA) will be performed on admission, and at 1, 24, at 48 hours, at the achievement of clinical stability, and whenever there is a clinical worsening. Patients enrolled in HFNC arm will continue HFNC oxygenation until clinical stability, defined as: Body temperature ≤ 37°C and ≥36°C for 24 consecutive hours Good ability in swallowing CRP and WBC normalization trend than the admission exams Hemodynamic stability Lack of respiratory distress SpO2 94-98% The primary outcome variable is the proportion of patients who reach the endotracheal intubation criteria - regardless of the actual intubation rate - within the first 48 hours of treatment. The primary analysis will be performed on the ITT population
CONDITIONS
Official Title
High Flow Nasal Cannulae vs Venturi Mask in Respiratory Failure Due to Pneumonia
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male or female of any ethnic group
- Age 18 years or older
- Respiratory rate at rest 20 breaths per minute or higher, or presence of severe respiratory distress
- PaO2/FiO2 ratio 250 or less during oxygen therapy with Venturi mask at FiO2 50% for at least 60 minutes
- Diagnosis of pneumonia as the sole cause of acute respiratory failure
- Informed consent obtained from patient or closest relative if patient unable to consent
You will not qualify if you...
- Acute respiratory failure caused by conditions other than pneumonia
- Unstable angina or ongoing acute myocardial infarction
- Acute respiratory acidosis with pH below 7.35 and PaCO2 above 45 mmHg
- Systolic blood pressure below 90 mmHg not responding to fluids or requiring amines
- Severe arrhythmias
- Epileptic seizures
- Kelly scale vigilance score greater than 3
- Impaired swallowing increasing risk of aspiration or inability to protect airways
- Craniofacial trauma or burns
- Uncooperative patient
- Presence of open wounds on skull, chest, or abdomen
- Respiratory arrest or need for intubation at enrollment
- Ongoing or suspected pregnancy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Vicky Rubini
Bergamo, Italy, 24127
Actively Recruiting
Research Team
R
roberto cosentini, MD
CONTACT
A
andrea duca, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here